Clinical Trial Update: Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating amrubicin plus cyclophosphamide in advanced solid organ malignancies, including lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Amrubicin (amrubicin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Lawrence Einhorn | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED